Pyrimethamine exerts significant antitumor effects on human ovarian cancer cells both in vitro and in vivo
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference31 articles.
1. Cancer statistics;Siegel;CA Cancer J Clin,2016
2. Committee opinion no. 620: Salpingectomy for ovarian cancer prevention.;Obstet Gynecol,2015
3. Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy;Oren;Int J Cancer,2016
4. Artemisinin and its derivatives as a repurposing anticancer agent: what else do we need to do?;Li;Molecules,2016
5. Unbiased compound screening identifies unexpected drug sensitivities and novel treatment options for gastrointestinal stromal tumors;Boichuk;Cancer Res,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pyrimethamine reduced tumour growth in pre-clinical cancer models: a systematic review to identify potential pre-clinical studies for subsequent human clinical trials;Biology Methods and Protocols;2024-01-01
2. Three molecular subtypes and a five‐gene signature for hepatocellular carcinoma based on m7G‐related classification;The Journal of Gene Medicine;2023-10-17
3. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects;European Journal of Medical Research;2023-09-14
4. Construction of a cuproptosis-associated long non-coding RNA risk prediction model for pancreatic adenocarcinoma based on the TCGA database;Medicine;2023-02-03
5. Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancer;Molecular Biology Reports;2022-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3